Pharmafile Logo
Pharmafocus logo
Advanced Search

Mylotarg

Showing 4 posts of 4 posts found.

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018
Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …

News
pfizer-building-logo1web

Pfizer’s drug back on the market after proving safety

September 5, 2017
Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …

News

Reaxa spins out specialist antibody-drug conjugate unit

October 19, 2010
Manufacturing and Production Mylotarg, Reaxa, antibody-drug conjugates

UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …

News

Pfizer withdraws blood cancer drug in US

June 22, 2010
Sales and Marketing AML, Mylotarg, Pfizer, blood cancer

The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026